| Original language | English (US) |
|---|---|
| Pages (from-to) | 247-250 |
| Number of pages | 4 |
| Journal | Indian Journal of Medical Research |
| Volume | 148 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 1 2018 |
Funding
Financial support & sponsorship: The first author (MDH) received support from the National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA for work related to this report (award R00HL107749). He also received support from the World Heart Federation to serve as senior programme advisor for the World Heart Federation’s Emerging Leaders program, which is supported by unrestricted educational grants from Boehringer Ingelheim and Novartis with previous support by AstraZeneca and BUPA. He has also received support from the American Heart Association, Verily, and AstraZeneca for work unrelated to this manuscript. The last author (DP) received unrestricted education grants from Merck Sharp & Dohma (MSD), Eli Lilly, GlaxoSmithKline, Torrent and Sun Pharmaceuticals for primary care physician training programmes.
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
